Skip to main content
VCbacked
Log inGet Started

Applikate Technologies

Washington, United States

Applikate Technologies is a hardware and software company that develops an automated histology platform with integrated digital imaging.

$2.6M raised
Aug 2021
Venture - Series Unknown
BiotechnologyHealth CareSoftware

Top Investors

Creative Destruction LabAndrew Nutter

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Applikate Technologies

How much funding has Applikate Technologies raised?
Applikate Technologies has raised $2.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2021.
Who are Applikate Technologies's investors?
Applikate Technologies's investors include Creative Destruction Lab, Andrew Nutter.
Where is Applikate Technologies headquartered?
Applikate Technologies is headquartered in Washington, United States.
What does Applikate Technologies do?
Applikate Technologies is a hardware and software company that develops an automated histology platform with integrated digital imaging.
What stage is Applikate Technologies at?
Applikate Technologies is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Applikate Technologies — Funding & Investors." VCBacked, August 26, 2021, https://www.vcbacked.co/company/applikate-technologies. Accessed July 3, 2026.
APA
VCBacked. (2021). Applikate Technologies — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/applikate-technologies
Wikipedia (cite web)
{{cite web |title=Applikate Technologies — Funding & Investors |url=https://www.vcbacked.co/company/applikate-technologies |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K